WC
TMO icon

Wexford Capital’s Thermo Fisher Scientific TMO Stock Holding History

Wexford Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-870
Closed -$506K – 260
2024
Q1 		$506K Buy
+870
New +$488K 0.1% 127
2020
Q4 		– Sell
-237
Closed -$105K – 381
2020
Q3 		$105K Buy
+237
New +$97.9K 0.03% 123
2014
Q4 		– Sell
-49,780
Closed -$6.06M – 97
2014
Q3 		$6.06M Buy
+49,780
New +$6.05M 0.56% 29
2014
Q1 		– Sell
-68,800
Closed -$7.66M – 256
2013
Q4 		$7.66M Sell
68,800
-52,120
-43% -$5.18M 0.66% 16
2013
Q3 		$11.1M Buy
120,920
+98,420
+437% +$8.9M 0.92% 16
2013
Q2 		$1.9M Buy
+22,500
New +$1.87M 0.17% 87

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wexford Capital's TMO Position: Q2 2024 in Review

Wexford Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 870 shares — an estimated $506K sold.

Wexford Capital first reported a position in TMO in Q2 2013 and held it in 6 quarters. The position peaked at $11.1M in Q3 2013. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Wexford Capital reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Wexford Capital sold 870 Thermo Fisher Scientific shares in Q2 2024, an estimated $506K.
  • Wexford Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 6 quarters.
  • Wexford Capital's Thermo Fisher Scientific position peaked at $11.1M in Q3 2013.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Wexford Capital's 13F filing for Q2 2024, filed 14 Aug 2024.